COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,893 Articles (22,568 medRxiv, 8,325 bioRxiv)

Most recent first Previous |  Page 446: Articles 4451-4460  | Next

A third vaccine dose equalizes the levels of effectiveness and immunogenicity of heterologous or homologous COVID-19 vaccine regimens
Guibert, N., Trepat, K., Pozzetto, B., Josset, L., Fassier, J.-B., Allatif, O., Saker, K., Brengel-Pesce, K., Walzer, T., Vanhems, P., Trouillet-Assant, S.
10.1101/2023.02.13.23285853 — Posted: 2023-02-21
Efficient Viral Capture and Inactivation from Bioaerosols Using Electrostatic Precipitation.
Preston, H. E., Bayliss, R., Temperton, N. J., Mayora Neto, M., Brewer, J., Parker, A. L.
10.1101/2023.02.19.529105 — Posted: 2023-02-21
Single shot dendritic cell targeting SARS-CoV-2 vaccine candidate induces broad and durable systemic and mucosal immune responses
Cheang, N. Y. Z., Tan, P. S., Purushotorman, K., Yap, W. C., Chua, B. Y. L., Tan, K. S., Tullett, K. M., Yeoh, A. Y.-Y., Tan, C. Q. H., Qian, X., Tay, D. J. W., Caminschi, I., Tan, Y. J., MacAry, P. A., Tan, C. W., Lahoud, M. H., Alonso, S.
10.1101/2023.02.21.529344 — Posted: 2023-02-21
Poor sleep quality, insomnia, and short sleep duration before infection predict long-term symptoms after COVID-19
Salfi, F., Amicucci, G., Corigliano, D., Viselli, L., Tempesta, D., D'Atri, A., Ferrara, M.
10.1101/2023.02.13.23285859 — Posted: 2023-02-21
Intrinsic and effective severity of COVID-19 cases infected with the ancestral strain and Omicron BA.2 variant in Hong Kong
Wong, J. Y., Cheung, J. K., Lin, Y., Bond, H. S., Lau, E. H. Y., Ip, D. K. M., Cowling, B. J., Wu, P.
10.1101/2023.02.13.23285848 — Posted: 2023-02-21
Athlete deaths during the COVID-19 vaccination campaign: contextualisation of online information
Binkhorst, M., Goldstein, D. J.
10.1101/2023.02.13.23285851 — Posted: 2023-02-21
An SEIDR Model for the Early Spread of COVID-19
Cao, T.
10.1101/2023.02.17.23286115 — Posted: 2023-02-21
A robust Platform for Integrative Spatial Multi-omics Analysis to Map Immune Responses to SARS-CoV-2 infection in Lung Tissues
Tan, X., Grice, L. F., Tran, M., Mulay, O., Monkman, J., Blick, T., Vo, T. Q. A., Almeida, A. C. S. F., Junior, J. d. S. M., de Moura, K. F., Machado-Souza, C., Souza-Fonseca-Guimaraes, P., Baena, C. P., de Noronha, L., Guimaraes, F. S. F., Luu, H. N., Drennon, T., Williams, S., Stern, J., Uytingco, C., Cooper, C., Short, K., Belz, G., Souza-Fonseca-Guimaraes, F., Kulasinghe, A., Nguyen, Q.
10.1101/2023.02.19.529128 — Posted: 2023-02-20
Genetic consequences of effective and suboptimal dosing with mutagenic drugs in a hamster model of SARS-CoV-2 infection
Illingworth, C., Guerra-Assuncao, J. A., Gregg, S., Charles, O. J., Pang, J., Roy, S., Abdelnabi, R., Neyts, J., Breuer, J.
10.1101/2023.02.20.529243 — Posted: 2023-02-20
Antibody-mediated cell entry of SARS-CoV-2
Kibria, M. G., Lavine, C. L., Tang, W., Wang, S., Gao, H., Shi, W., Zhu, H., Voyer, J., Rits-Volloch, S., Keerti, F., Bi, C., Peng, H., Wesemann, D., Lu, J., Xie, H., Seaman, M. S., Chen, B.
10.1101/2023.02.20.529249 — Posted: 2023-02-20

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).